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Abstract
Imaging technologies allow assessing of complex structures and underlying dynamic biological processes that
take place deep within the human body. A number of imaging modalities that exist today exploit the very depth
of the energy spectrum. Light microscopy techniques ranging from confocal to multi-photon to super-resolution
fluorescence microscopy, electron microscopy, fluorescence tomography, mass spectrometry imaging, and
bioluminescence imaging are widely employed in today’s medical research. Clinical imaging techniques such as
X-ray computed tomography (CT), Positron Emission Tomography (PET), magnetic resonance imaging (MRI),
ultrasound, and light-based methods [endoscopy and optical coherence tomography (OCT)] are frequently used
as a part of clinical diagnostics. The integration of clinical and research modalities is vital to obtain critical
information pertaining to therapeutic success of promising therapeutics, particularly in the emerging field of
cell based therapies for various medical conditions.
Keywords: Imaging, Optical imaging, Stem cell therapies

Introduction
Recent developments in imaging technologies to
detect molecular and biological processes have
helped identify numerous human disorders and have
also paved path to novel therapeutics. The advent of
non-invasive super resolution imaging technologies
in vivo is essential for understanding diseases and
the development of new therapeutics. The major
goal for this technology is to provide monitoring
of various biological processes in vivo at the cellular
and molecular level that include tumor regression
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or progression, gene expression; various drug and
gene therapies.1-3 Noninvasive molecular imaging
technologies provide an excellent way to visualizing
living cells in vivo and is vital to visualize the fate of
cells in vivo.2
Stem cells have emerged as promising cellular
delivery vehicles. Due to their inherent migratory
properties, stem cells can be used for the delivery
of therapeutic proteins in a variety of human
cancers. Stem cells have remarkable potential
in developmental biology, drug discovery, and
regenerative medicine; imaging techniques are
often employed to evaluate the purity, state of
differentiation, number, and location of these cells.
There are several sources from which stem cells
can be obtained. Primarily, mesenchymal stem cells
(MSCs), have been obtained from bone marrow of
healthy adult donors or other tissue sources. Neural
stem cells; induced pluripotent stem cells (iPSC)
that are reprogrammed from adult fibroblasts by
employing several transcription factors.4,5 Imaging
stem cells provides important data regarding the
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behavior and function of these cells including
their location, protein expression levels, viability,
percent viability, and differentiation status, as well
as interactions between the cells and the adjacent
tissue. Molecular imaging is a rapidly expanding
field in biomedical research that allows us to quantify
biological processes at sub-cellular levels within
living organisms. Molecular imaging offers a novel
and noninvasive approach to obtain a wide range of
information using several probes targeted towards
unique biomarkers expressed on cellular surfaces.
Several developments have emerged in imaging
methods that can be utilized to visualize various in
vivo models of disease at a very high resolution.
These techniques include magnetic resonance (MR)
imaging, several radionuclide imaging techniques
such as single photon emission tomography
(SPECT), and positron emission tomography
(PET). Alternatively, optical techniques for imaging
that employ physical parameters of light interaction
with tissues have also been demonstrated extensively.
Optical imaging techniques rely on reflectance,
absorption, fluorescence or bioluminescence as a
source of contrast.5 More recent optical imaging
techniques, which are becoming more popular
include near fluorescence-mediated tomography,
intra-vital microscopy and infrared fluorescence
(NIRF) imaging. Numerous such technologies have
been recently developed to track the fate of cellbased therapies in experimental models and this have
greater implications in developing novel therapeutic
strategies for various conditions.5
Imaging technologies to track fate of cell based
therapeutics
Optical imaging techniques allow the direct
observation of cellular and molecular processes
both in culture and in experimental models of
disease. These techniques rely on the capture of
optical photons and can be divided into fluorescence
imaging and bioluminescence imaging. Advantages
of optical imaging include the sensitivity and the
possibility to image multiple labels with different
characteristics at the same time. However, a major
downside to optical imaging is a lack of penetration
depth (especially with visible wavelengths), due to
light scattering by the tissue.

Fluorescence imaging
Fluorescence imaging uses fluorescent probes that,
when illuminated with light of a certain wavelength,
will absorb the energy and emit photons of longer
wavelengths. External light of specific wavelengths
is employed to excite fluorescent molecules in the
target that emit photons of longer wavelength
(and accordingly, of lower energy), which are
subsequently registered by a detector. Optical
visualization of fluorescence has been extensively
employed for in vitro and ex vivo imaging of target
molecules in cell biology. Currently, fluorescenceimaging techniques are being successfully expanded
towards in vivo imaging.6,7 In vivo fluorescence
imaging techniques cover a wide range of resolution,
sensitivity, and imaging depths. A study by Jang et
al. reports the combination of a neuronal promoter
based reporter system where in fluorescence
imaging were utilized in live cells to visualize the
enhanced differentiation of neuronal progenitor
cells (NPCs) with overproduction of microRNA
(miR)-124a in vitro and in vivo.4 Various fluorescent
probes have been developed to facilitate imaging in
animal models of disease. These probes range from
conventional small organic fluorophores to recent
discovery of quantum dots that possess a high photo
stability that allow for repeated visualizations.5
The discovery of fluorescence proteins, particularly
the green fluorescent protein (GFP) from the
jellyfish Aequorea victoria has changed perspectives
of biological visualization. GFP achieves its native
conformation and generates its chromophore without
addition of any cofactors thus making it a universal
fluorescent marker.5 Shah et al. have engineered
several different lentiviral vector constructs that
express fluorescent and bioluminescent fusion
proteins. These vectors were validated in human
glioblastoma cells and adult stem cells.8-10 The
engineered tumor and stem cells were shown to
express the fusion proteins at high intensity and
the expression was preserved over repeated cell
culture. Human stem cells were reported to retain
their stemness following transduction and also their
potential to differentiate into neuronal cells and
astrocytes. These studies reveal that transduced
stem cells retain allow a way to be tracked by optical
imaging methods. 8-10
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Fluorescence imaging has several advantages:
(i) it does not require the administration of a
substrate that has to be enzymatically modified to
emit photons. (ii) It allows for exploiting different
fluorophores with different excitation and emission
spectra to acquire multiple signals, monitoring
different processes in the same experimental animal.
(iii) The same fluorescent signal can be used for
monitoring a specific molecular process in vivo and
further validating it by fluorescence microscopy ex
vivo.6,7 However, fluorescence imaging requires the
use of an excitation light that could be attenuated
by the tissues with a consequent lower excitation
efficiency of deeply located fluorochromes, and
it is characterized by a significant amount of
auto-fluorescence. Thus, the quantification of a
fluorescent signal can be difficult.6,7
Bioluminescence imaging (BLI)
Bioluminescence imaging often referred as
chemiluminescence uses a construct for luciferase
production. Luciferase, an enzyme that catalyzes
a chemical reaction involving the conversion of
luciferin to oxyluciferin, which results in emitted
light. The overall aim is to capture the emitted light
from the experimental animal using a charge-coupled
device. The emitted light intensity is presented with
a pseudo-color scale of the bioluminescent images.
The scaled representation of emitted light allows
for attributing a gradient of differential emitted
light. These images obtained are then overlaid light
images of the experimental animal(s), which are
captured during the imaging session. This allows
to clearly differentiate the anatomical location of
the emitted light thereby able to assess or track the
parameters that are being followed over time.3
BLI offers numerous advantages in terms of the
sensitivity and non-invasive nature of the technique
and thereby is widely accepted in various animal models
of oncology.11 The incorporation of bioluminescent
markers allows for a continuous tracking of the
progression thereby serving as a checkpoint for both
establishment of the disease in experimental models
and also to track the effectiveness of a therapeutic
agent or a test compound. BLI has widely been
utilized for visualization of a variety of biological
processes in vivo, owing to its sensitivity, ease of
14
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use, and lower operational expense.11 Disadvantages
include a limited penetration depth and poor spatial
resolution, as a result of light scattering by the
tissue.
BLI has emerged as the preferred imaging technique
particularly in smaller laboratory animals such
as rodents for optical tracking of cells. This
technology enables simultaneous dual visualization
of different luciferases that allows distinguishing
between different processes being investigated.12,13
Dual luciferase gene activities in the same animals
contribute to reduction in experimental variations as
a result of procedures performed or differences in
animals. Wang et al.14 reported a successful imaging
of differentiation of stem cells to predict response
of a novel stem cell therapy by utilizing the dual
luciferase reporters: the Renilla Luciferase gene
and the firefly luciferase gene.12,13 Luciferases that
are obtained from various species utilize differing
substrates and emit lights at various wavelengths
that allow for simultaneous bioluminescence
imaging of transplanted neural stem cells in vivo in
the brain.12 Bioluminescence imaging of Fluc and
Rluc provided the real-time monitor of tumor cells
and hUC-MSCs administered simultaneously in
breast cancer therapy.15
Magnetic resonance imaging (MRI) MRI is a
noninvasive imaging technique that provides
insights into the anatomy, function, and metabolism
of tissues in living subjects without the use of any
ionizing radiation. Nowadays, MRI technology is
moving beyond anatomical or structural imaging. It
is also employed for dynamic and functional imaging.
MRI makes investigation of various aspects of
tumor cell biology possible and allows assessing the
response to a specific therapy. The ability to track
the path of therapeutic cells post transplantation is
critical to assess effectiveness of such therapies.
Owing to its inherent high spatial resolution, MRI
serves as an ideal imaging modality to understand
the fate of cellular therapies in vivo16 . To detect the
transplanted cells by MRI with high sensitivity, it is
necessary to label them with magnetic nanoparticles
(MNPs) prior to their implantation. This technique
induces contrast that allows for MRI imaging
without altering the functional properties and also
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allows for detection of few hundred cells. Thus,
when paired with other imaging techniques, like
PET or BLI, MRI can provide insight into important
grafting parameters such as optimal cell “dose”, that
can be in the clinical implementation of a novel cell
therapies.17 To determine some of these parameters
in a reliable manner, for instance graft volume or
cell proliferation, very precise titration controls are
needed to determine the detection limit of the MRI
equipment.
Radionuclide imaging including PET and singlephoton emission computed tomography (SPECT),
is based on registering ionizing radiation.18-20
This imaging modality has a greater sensitivity
and the best spatial resolution across all imaging
modalities that are currently being employed21-22.
In the clinics, it has been widely used to assess
several pathophysiological functions in humans.
Radioisotopes that have a longer decay half-life
are selected for labeling and tracking cells.23 PET
imaging quantitatively detects the high-energy
γ-rays emitted from isotopes or labeled molecular
probes. Advantages of PET imaging are: high
sensitivity, it is non-invasive, it allows real time
tracking in vivo, and it is not dependent of the depth
of the emitted signal.
A PET tracer is designed in a way that it promotes
reflection of specific biochemical processes being
studied in the body. The PET camera captures
emitted photons by positron annihilation events
radioisotopes, such as F-18. They can be linked to a
molecule of interest like 2-deoxy-2- [18F] fluoroD-glucose (FDG) that aids in tracking glucose
metabolism in the body. Jin et al. have investigated the
potential of in vivo radionuclide imaging of CSCs
using Iodine-125-labeled ANC9C5, an anti-human
CD133 antibody, in colon carcinoma xenografts.
Although a favorable biodistribution profile was not
obtained, intratumoral distribution of 125I-labeled
ANC9C5 depicted on autoradiography was
overlapped with CD133 immunohistochemistry
expression in many areas.24
Gaedicke et al. performed PET imaging to detect an
epitope of the second extracellular loop of CD133.
Specifically, two cell lines overexpressing CD133

were xenografted in mice and imaged using 64CuNOTA-AC133. The imaging yielded accurate and
high-resolution images of brain tumor lesions 2-3
mm in size, with significant tumor-to-background
contrast. This study disclosed the differences in
invasive behavior between orthotopically growing
U251 (noninvasive) and NCH421k (invasive) gliomas.
More interestingly, PET signal intensity accurately
reflected the microscopic pattern of tumor AC133+
expression. This was observed in sharply delineated
PET images of U251 tumor that has compact and
spherical microscopic appearance. On the other
hand, the chaotic and infiltrative growth pattern in
NCH421k tumors was represented by more diffuse
PET signal.
The tumor cell homing of MSC has been investigated
by employing reporter gene labeling.25 MSC were
engineered to express HSV-TK, which serves as an
imaging tracer for PET studies. Using the fluorine18-labeled acycloguanosine derivative substrate (9(4-[18F] Fluoro-3-hydroxymethylbutyl) – guanine)
tracer [18F] FHBG, an increased tracer uptake in
glioblastoma tumors following FHBG administration
and imaging was observed.25 Further, these findings
were validated employing a multimodal PET/MRI
system and a 2-photon laser scanning microscopy.
Thus, radionuclide imaging has proven to be
extremely efficient in tracking cells in vivo and
is often used in conjunction with modalities to
constitute a multimodal imaging approach.
Future of imaging based approaches to
determine fate of therapies
Rapid advances in imaging technologies over the
past decade certainly promise a bright future in this
field. Tremendous potential exists to further advance
imaging capabilities in basic science, translational
and clinical practice. These novel tools will most
definitely allow for newer types of measurements.
The techniques that specifically are capable of
quantitative and comprehensive assessment of
the cellular and/or subcellular events in vivo will
be very valuable to validate efficacy of promising
therapeutics. Today a number of opportunities
certainly exist in the world of imaging such as
methods to improve clinical detection of earlier
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forms of cancers to <1 mm3, strategies to develop
single cell imaging techniques to image beyond
the current depth capabilities and development of
techniques to achieve resolution at the cellular level.
These are a few of the very many challenges that
could be tackled to make medical discoveries more
promising and to accelerate translation of promising
therapies from bench to bedside.
To conclude, the world of imaging has critically
contributed to various aspects of basic science,
translational sciences, and clinical medicine. We are
confident that the future holds promise and novel
developments will emerge allowing us to push the
boundaries in terms of how efficiently the fate of
novel therapeutics can be evaluated at a much deeper
level.
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